The British Pharmacopeia (BP) and the United States Pharmacopeia (USP) formalized their long-standing Partnership to strengthen the quality of medicines and improve public health around the world, in an agreement signed on Friday, July 26, at USP in Rockville, MD. Pharmacopoeial quality standards help drug manufacturers and regulatory agencies ensure medicines quality.
The formal Memorandum of Understanding establishes a framework for cooperative activities, including developing drug product monographs, information sharing, and expanding collaboration to new areas. The organizations intend to exchange scientific staff and participate in joint events.
Posted by Dr. Tim Sandle, Pharmaceutical Microbiology
